Determinants and levels of cervical Cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa Demographic and health survey data, 2016

被引:24
作者
Akokuwebe, Monica Ewomazino [1 ]
Idemudia, Erhabor Sunday [1 ]
Lekulo, Abiel M. [1 ]
Motlogeloa, Ogone Warona [1 ]
机构
[1] North West Univ, Fac Humanities, Mafikeng, South Africa
关键词
Cervical cancer; Determinants; Levels; Reproductive age; Women; Screening; South Africa; HUMAN-PAPILLOMAVIRUS; GLOBAL CANCER; RISK; PREVALENCE; COUNTRIES; SURVIVAL; BURDEN; STAGE;
D O I
10.1186/s12889-021-12020-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Cervical cancer (CC) is the cancer with the most incidents and the leading cause of cancer mortality among women in South Africa. CC screening is one of the most cost-effective control approaches for the disease burden. This study assessed the determinants and individual-level indicators of cervical cancer screening uptake among women of reproductive age in South Africa. Methods We analyzed data from the 2016 South Africa Demographic Health Survey. Our analysis focused on 5903 women (15-49 years). We conducted Chi-square test for bivariate analysis, and multivariate binary logistics regression was used to analyze independent association between individual-level factors and women who have had Pap smear testing. Statistical significance was set at p < 0.05. Results The mean age at cervical cancer screening uptake among women in South Africa was 40.8 years (SD 18.6, range 15-95 years). A majority of the women (39.3%) were aged 45 years and above and 54.6% of them resides in urban settlements. About 35.4% of women (n = 2098) have had a Pap smear test, with 66.5% of them who had a Pap smear test resides in Western Cape province. The proportion of women who had a Pap smear test was significantly higher among those with higher educational attainment (68.7%, p = 0.000), in the rich wealth index (50.1%, p = 0.000), and those with health insurance cover (60.3%, p = 0.000). Pap smear testing was found to be more prevalent among women aged 45(+) years, were in the white population group, had higher education, were divorced, and had health insurance cover. The predominance of Pap smear test was 14% higher among women who are working in the professional/formal sector (AOR; 1.38, 95% CI; 1.14-1.69). The uptake of Pap smear test was also higher among women aged 35-44 years. Conclusions The prevalence of cervical cancer uptake is substantially low among women aged 15-24 years in South Africa and shows a degree of between-provinces differences. Therefore, heath educational interventions aimed at increasing the uptake of cervical cancer screening services in South Africa are critically needed.
引用
收藏
页数:14
相关论文
共 76 条
  • [1] Abdikarim IK, 2017, J COMM PUB HLTH NURS, V03, DOI [10.4172/2471-9846.1000159, DOI 10.4172/2471-9846.1000159]
  • [2] Cervical Cancer Screening Among College Students in Ghana Knowledge and Health Beliefs
    Abotchie, Peter N.
    Shokar, Navkiran K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (03) : 412 - 416
  • [3] The association between socioeconomic factors and breast cancer-specific survival varies by race
    Agarwal, Shailesh
    Ying, Jian
    Boucher, Kenneth M.
    Agarwal, Jayant P.
    [J]. PLOS ONE, 2017, 12 (12):
  • [4] Ahmed Hussain Gadelkarim, 2017, Asian Pac J Cancer Prev, V18, P1543, DOI 10.22034/APJCP.2017.18.6.1543
  • [5] Akokuwebe M. E., 2015, Research on Humanities and Social Sciences, V5, P1
  • [6] Akokuwebe ME, 2019, NIGERIA OMAN MED J, V34, P444, DOI [10.5001/omj.2019.81, DOI 10.5001/OMJ.2019.81]
  • [7] Akokuwebe ME, 2017, ILORIN J SOCIOLOGY, V9, P200
  • [8] Prevalence, risk-inducing lifestyle, and perceived susceptibility to kidney diseases by gender among Nigerians residents in South Western Nigeria
    Akokuwebe, Monica Ewomazino
    Odimegwu, Clifford
    Omololu, Femi
    [J]. AFRICAN HEALTH SCIENCES, 2020, 20 (02) : 860 - 870
  • [9] [Anonymous], 2018, STAT S AFR GEN HOUS
  • [10] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
    Arbyn, Marc
    Weiderpass, Elisabete
    Bruni, Laia
    de Sanjose, Silvia
    Saraiya, Mona
    Ferlay, Jacques
    Bray, Freddie
    [J]. LANCET GLOBAL HEALTH, 2020, 8 (02): : E191 - E203